Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Key Takeaways From Molina Healthcare Analyst Ratings
Molina Healthcare Analyst Ratings
Truist Securities Maintains Buy on Molina Healthcare, Lowers Price Target to $400
Analysts Conflicted on These Healthcare Names: Daiichi Sankyo Company (OtherDSKYF), Inovio Pharmaceuticals (INO) and Molina Healthcare (MOH)
Molina Healthcare Analyst Ratings
JPMorgan Adjusts Price Target on Molina Healthcare to $395 From $420
Stephens Adjusts Price Target on Molina Healthcare to $320 From $355
Barclays Adjusts Price Target on Molina Healthcare to $359 From $430, Maintains Equalweight Rating
Molina Healthcare Analyst Ratings
JPMorgan Adjusts Price Target on Molina Healthcare to $420 From $435
Wells Fargo Reaffirms Their Hold Rating on Molina Healthcare (MOH)
Molina Healthcare Analyst Ratings
Baird Initiates Molina Healthcare With Outperform Rating, $405 Price Target
Molina Healthcare Analyst Ratings
TD Cowen Adjusts Price Target on Molina Healthcare to $412 From $453, Keeps Buy Rating
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Molina Healthcare (MOH) and Cytokinetics (CYTK)
Molina Healthcare Analyst Ratings
Wells Fargo Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $375
Goldman Sachs Adjusts Molina Healthcare Price Target to $442 From $463